by country – Page 21 – Retraction Watch

Journal expresses a great deal of concern over deceased author’s work

A gastroenterology journal has issued an extensive expression of concern about a 2013 paper by Yoshihiro Sato, a Japanese endocrinologist who has posthumously been climbing the Retraction Watch leaderboard. (He’s now ranked number three, ahead of Diederik Stapel.)

To call the statement an “expression of concern” is like calling Charles M. Schulz a talented cartoonist, or Escoffier a pretty good cook. Indeed, the journal expresses so much concern, about, well, so much, that we’re not sure what in the paper would be left unscathed.

Sato, formerly of Hirosaki University, currently has 77 retractions for a range of misconduct-related issues including likely data fabrication and duplication.

Authors object as “doubtful” data doom dermatology paper

A dermatology journal has retracted a 2017 article by a pair of researchers in Saudi Arabia after receiving a “serious complaint” about the integrity of the data. But the first author of the paper pushed back, saying the move was unjustified.

The article, “Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa,” was written by Ibrahim Al-Homood and Mohammad Aljahlan, rheumatologists at King Fahad Medical City in Riyadh and appeared in the Journal of Dermatology & Dermatologic Surgery. It described (with rather grisly pictures) the case of a 25-year-old man with severe leg ulcers that resolved after the described combination therapy.

But at the notice explains, the paper can’t be trusted:

Kyoto University suspends first author of retracted Kumamoto quake paper

Damage from the 2016 Kumamoto earthquake

The first author of a now-retracted paper in Science about the effects of the deadly 2016 Kumamoto earthquake in Japan has been suspended from his university position for one year.

Aiming Lin, of the Department of Geophysics at Kyoto University, was sanctioned by the institution for misconduct stemming from his misuse of data and plagiarism in the 2016 paper:

OSU cancer researcher Carlo Croce loses appeal of New York Times libel suit

Carlo Croce, a prolific cancer researcher at The Ohio State University (OSU) in Columbus who was the subject of a 2017 front page story in The New York Times about allegations of misconduct against him, has lost a libel suit that he filed against the newspaper.

As first reported by Courthouse News Service earlier this week, the Sixth Circuit upheld a lower court’s November 2018 ruling tossing most of Croce’s claims. In the ruling, U.S. Circuit Judge Karen Moore writes:

Criminologist posts 27-page article explaining why he asked for one of his papers to be retracted

On Sunday, May 5 of this year, Justin Pickett received an email from a “John Smith” with the subject line “Data irregularities and request for data.”

“There seem to be irregularities in the data and findings in five articles that you published together with two surveys,” the anonymous correspondent wrote. “This document outlines those irregularities.”

Pickett was a co-author on only one of the papers, “Ethnic threat and social control: Examining public support for judicial use of ethnicity in punishment,” which was published in 2011 — the year he earned his PhD from Florida State University (FSU) — in the journal Criminology. The other four papers were published from 2015 to 2019 in Criminology, Law & Society Review, and Social Problems. The only author common to all four was Eric A. Stewart, a professor at FSU.

Cancer specialists in Mexico earn third retraction following questions about their data

Cases of cancers seen at the Instituto Mexicano del Seguro Social, according to researcher Agustin Avilés

A group of cancer researchers in Mexico has lost their third paper over concerns about the integrity of their data.

Neither the new retraction, in the journal Hematology, nor the previous two, cite misconduct as the reason for the removals. However, the statements do refer to lack of reliability of results, “ambiguities and inconsistencies” in the findings and other serious issues.

The first author on each paper is Agustin Avilés, whom the Hematology article listed as being with the National Medical Center in Mexico City.

According to the retraction notice:

Georgia State researcher has two papers retracted, eight flagged. He’s not happy about it.

The Journal of Biological Chemistry has retracted two papers by a Georgia State University researcher, as well as flagged eight more with expressions of concern, a move the scientist called “unfair and unjustified.”

Ming-Hui Zou, the common author on all ten papers — as well as on two more that have been corrected by the same journal — is, according to Georgia State,

an internationally recognized researcher in molecular and translational medicine and a Georgia Research Alliance Eminent Scholar in Molecular Medicine and associate vice president for research at Georgia State University…

Zou was at the University of Oklahoma when the papers in question were published. He moved to Georgia State in 2015.

Here’s the retraction notice for “Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo,” published in 2008 Zou as the last author:

An author told a journal their institution had no one who handled allegations. Turns out that wasn’t true.

Should journals always take authors at their word?

Take the case of a recent expression of concern in the Journal of Cell Science following concerns about image manipulation in a 2006 paper, “Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.”

Here’s the notice:

Public health journal retracts paper on austerity for “inaccurate and misleading results”

The American Journal of Public Health has retracted a controversial 2018 paper on the effects of economic austerity in Spain because it contained “inaccurate and misleading” results linking those policies to a massive spike in premature deaths.

The journal also has published a second piece, by a different group of authors, refuting the central claim of the now-retracted paper. Whereas the first article asserted that austerity in Spain during the mid-2000s led to more than 500,000 excess deaths, the new research says deaths in the country slowed during the country’s economic crisis.

The flawed article, “Austerity policies and mortality in Spain after the financial crisis of 2008,” was written by a group of researchers at the Hospital Universitario Nuestra Señora de Candelaria, in Santa Cruz de Tenerife, on the Canary Islands. The authors claimed that their analysis of the years 2011 to 2015 showed that:

A university requested retractions of eight papers. It took journals a year to yank four of them.

On March 30, 2018, The Ohio State University (OSU) released a 75-page report concluding that Ching-Shih Chen, a cancer researcher, had deviated “from the accepted practices of image handling and figure generation and intentionally falsifying data.” The report recommended the retraction of eight papers.

By the end of August of 2018, Chen had had four papers retracted — one in Cancer Research, two in the Journal of Medicinal Chemistry, and one in PLoS ONE.

But it wasn’t until more than a year after the report was released that the other four papers — two from Carcinogenesis, one from Clinical Cancer Research, and one from Molecular Cellular Therapeutics — were retracted, all between April 1 and May 1 of this year.

What took so long? Your guess is as good as ours; none of the editors of those journals responded to our requests for comment.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: